Unaided awareness of EMD Serono's Mavenclad (cladribine tablets) and Novartis' siponimod increased compared to previous quarters, but neurologists appear split on how, or if, they will incorporate the newest agents into their multiple sclerosis armamentarium, according to a new report from Spherix Global Insights
Pritzker Group Venture Capital Leads Round, Pushing Apprentice past $10M Mark
Arete Pharmacy Network to become wholly owned
Data validity is the cornerstone of evidence-based medicine. As randomized controlled trials are augmented by real-world evidence, data validity has come under question.
Initial excitement associated with the completion of genome-scale CRISPR screens can quickly turn to dismay as the realization of the sheer quantity of data generated becomes apparent.
AAV Wizard streamlines AAV production workflow from vector design to packaging
Open invitation to the Biopharma Industry as Almac's experts continue to showcase expertise
What does it mean to have a truly site-centric supply chain? In the past, site forecasting was considered avoiding stock-out. This is no longer the case.
CROs are finding themselves operating in an increasingly competitive market, where true differentiation is hard to achieve. In order to stand out from the competition, today's CROs need to offer something more.
With no current FDA approved biologics for the treatment of non-radiographic axial spondyloarthropathy, overall penetration of biologics/JAKs is significantly lower than for ankylosing spondylitis; however, when these agents are prescribed, brand usage closely mirrors the ankylosing spondylitis indication, according to a new publication by Spherix Global Insights
Annual Prestigious Prize Worth $35,000 Drives Critical Research Area
Following on from the second webinar in this 4-part series, "Quality In, Quality Out: Regulatory Drivers of Supplier Quality Management in the Medical Device Industry," this third presentation will take a specific and deeper dive into the regulatory requirements for supplier management for the pharmaceutical and biopharma industries.
Company also announces appointments to Scientific Advisory Board
Pharmafranchiseeindia.com is among the best online pharmaceutical portals that list the pharma franchise companies in India and third party manufacturers providing lucrative pharma franchise opportunities across the length and breadth of India.
Non-Dilutive Investment and Product License includes licensing fee and development costs
EQuIPP™ Analytics is a next-generation visual reporting platform providing unparalleled strategic insights into modern value-based programs.